Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992-Reference-Cited by-同舟云学术

Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992

Published:2001-09 Issue:3 Volume:114 Page:539-543
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Andersen Mette Klarskov,Christiansen Debes H.,Jensen Bjarne Anker,Ernst Peter,Hauge Gunnar,Pedersen-Bjergaard Jens

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2001.03000.x/fullpdf

Reference28 articles.

1. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements;Andersen;Haematologica,1998

2. Secondary acute lymphoblastic leukemia with t(4;11);Auxenfants;Annals of Hematology,1992

4. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia. Correlation with scaffold attachment regions and topoisomerase II consensus binding sites;Broeker;Blood,1996

5. Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary leukemias;Cimino;Cancer Research,1997

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Caffeine intake during pregnancy and adverse outcomes: An integrative review;Reproductive Toxicology;2024-01

2. Epigenetic balance ensures mechanistic control of MLL amplification and rearrangement;Cell;2023-10

3. Mechanisms of Secondary Leukemia Development Caused by Treatment with DNA Topoisomerase Inhibitors;Biochemistry (Moscow);2023-07

4. Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal;Blood Advances;2023-06-30

5. A secondary CD34+ acute lymphoblastic leukemia unmasked and mobilized by G‐CSF in an autologous stem cell donor with testicular cancer;Transfusion;2023-02-10